Oncodesign and the Laboratory for Neurobiology and Gene Therapy at the KU Leuven enter into a research collaboration for advancing drug discovery efforts with Ipsen in Parkinson's disease

18/12/12

DOWNLOAD

Oncodesign enters into a research collaboration and license agreement with Sanofi for the application of Oncodesign’s Nanocyclix® technology to Sanofi’s Kinase targets

13/09/12

DOWNLOAD

Oncodesign and Ipsen enter into a research collaboration for the development of new therapeutic agents against the LRRK2 Parkinson's disease target

05/01/12

DOWNLOAD

Ce site utilise des cookies afin de fournir des services, analyser le trafic ou faciliter la navigation.